Tag: Dpi

Studies show that incorrect inhaler technique is common, with some analyses finding only 31% of patients use their device correctly [1.5.5]. When considering **which is better pMDI or DPI inhaler**, understanding their fundamental differences is crucial for effective treatment of asthma and COPD.

According to the Centers for Disease Control and Prevention (CDC), millions of people in the United States have chronic lung conditions like asthma or COPD, with handheld inhalers being a common treatment option. To ensure effective medication delivery, patients must understand the differences between the three types of inhalers, which include Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), and Soft Mist Inhalers (SMIs).

According to a study published in *Drugs*, between 82% and 91% of patients use their inhalers incorrectly, a major concern that the Novolizer seeks to address with its innovative design. This advanced device is a **multidose dry powder inhaler (DPI)**, engineered to significantly improve medication delivery and patient compliance through advanced feedback mechanisms.

Medication delivery errors with inhalers are common and can compromise treatment effectiveness. This is precisely why the **Genuair** inhaler was designed as a breath-actuated, multi-dose dry powder inhaler (DPI) with sensory feedback to simplify its use and improve patient outcomes.

Tyvaso is a critical medication for patients with pulmonary hypertension, with clinical studies demonstrating its ability to improve exercise tolerance. Correct administration is essential for achieving the intended therapeutic effects, and knowing **how to administer Tyvaso** accurately is crucial for patient safety and efficacy.